July 20, 2024
5 min watch
On this Healio Video Perspective from the ASRS assembly, Danny Mammo, MD, of Cole Eye Institute discusses the real-world impact of triamcinolone acetonide on IOP in sufferers with uveitic macular edema.
The multicenter retrospective evaluation included 60 eyes of 54 sufferers who had a historical past of glaucoma, ocular hypertension or steroid response. Of 26 sufferers with prior steroid IOP response with out incisional glaucoma surgical procedure, 70% didn’t expertise an IOP rise at first follow-up after one suprachoroidal injection of triamcinolone acetonide.
“We predict these outcomes are important as a result of they present that suprachoroidal steroid injection could also be a safer, however not utterly secure, different in these high-risk sufferers with IOP points which have uveitic macular edema,” Mammo stated.
Sources/Disclosures
Collapse
Mammo D. Intraocular strain outcomes following suprachoroidal triamcinolone acetonide in sufferers with glaucoma, ocular hypertension, or steroid response. Introduced at: American Society of Retina Specialists annual assembly; July 17-20, 2024; Stockholm.
Disclosures:
Mammo reviews consulting for Bausch + Lomb.
